Praxis Precision Medicines
PRAX
PRAX
113 hedge funds and large institutions have $762M invested in Praxis Precision Medicines in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
12.55% less ownership
Funds ownership: 120.24% → 107.68% (-13%)
22% less capital invested
Capital invested by funds: $971M → $762M (-$209M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
113
Holding in Top 10
5
Calls
$35.4M
Puts
$38.1M
Top Buyers
| 1 | +$44.3M | |
| 2 | +$32M | |
| 3 | +$20.5M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$16.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.7M |
Top Sellers
| 1 | -$28.1M | |
| 2 | -$25.9M | |
| 3 | -$13.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.7M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$10.3M |